⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tgct

Every month we try and update this database with for tgct cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor PatientsNCT04938180
Tenosynovial Gi...
Pigmented Villo...
TGCT
PVNS - Pigmente...
AMB-05X
18 Years - AmMax Bio, Inc.
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorNCT04192344
Neoplasms
Tenosynovial Gi...
ABSK021
18 Years - Abbisko Therapeutics Co, Ltd
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)NCT05417789
TGCT
Emactuzumab
Placebo
12 Years - SynOx Therapeutics Limited
Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCTNCT05277454
Advanced Malign...
TGCT
HMPL-653
18 Years - 75 YearsHutchmed
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in JapanNCT04703322
Tenosynovial Gi...
Pexidartinib
20 Years - Daiichi Sankyo
Exercise in Testicular Germ Cell Cancer SurvivorsNCT05063760
Testicular Germ...
aerobic-strengt...
25 Years - 55 YearsSlovak Academy of Sciences
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in JapanNCT04703322
Tenosynovial Gi...
Pexidartinib
20 Years - Daiichi Sankyo
A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor PatientsNCT04938180
Tenosynovial Gi...
Pigmented Villo...
TGCT
PVNS - Pigmente...
AMB-05X
18 Years - AmMax Bio, Inc.
Study of Vimseltinib for Tenosynovial Giant Cell TumorNCT05059262
Tenosynovial Gi...
Pigmented Villo...
Giant Cell Tumo...
Tenosynovial Gi...
Tenosynovial Gi...
vimseltinib
Placebo
18 Years - Deciphera Pharmaceuticals LLC
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the KneeNCT04731675
Tenosynovial Gi...
Pigmented Villo...
AMB-05X
18 Years - AmMax Bio, Inc.
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in JapanNCT04703322
Tenosynovial Gi...
Pexidartinib
20 Years - Daiichi Sankyo
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the KneeNCT04731675
Tenosynovial Gi...
Pigmented Villo...
AMB-05X
18 Years - AmMax Bio, Inc.
A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military ServicemenNCT00341588
Testicular Canc...
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid TumorsNCT01804530
Solid Tumor
Tumors of Any H...
Tenosynovial Gi...
PLX7486 TsOH
18 Years - Plexxikon
Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCTNCT05277454
Advanced Malign...
TGCT
HMPL-653
18 Years - 75 YearsHutchmed
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorNCT04192344
Neoplasms
Tenosynovial Gi...
ABSK021
18 Years - Abbisko Therapeutics Co, Ltd
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)NCT05417789
TGCT
Emactuzumab
Placebo
12 Years - SynOx Therapeutics Limited
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: